Perspectives on the 2018 HHS Drug Pricing Guidance
FDA Commissioner Scott Gottlieb, M.D., will give remarks based on President Trump’s ‘Blueprint’ to Lower Drug Prices at this reporter briefing. Following Gottlieb, a panel of industry leaders and stakeholders will respond to the new drug pricing guidance.